Navigation Links
Researcher Receives Free C6 Flow Cytometer(R) System as First Winner of Accuri Flow Cytometer(R) Creativity Awards Program
Date:12/11/2008

-Accuri Is Awarding a Free Bench-Top Flow Cytometer System Twice Yearly to Support Innovative Research and Expand the Use of Flow Cytometry-

-Learn More about the Revolutionary Accuri C6 Flow Cytometer at the American Society for Cell Biology Annual Meeting-

ANN ARBOR, Mich., Dec. 11 /PRNewswire/ -- Accuri Cytometers Inc., a life sciences company developing revolutionary bench-top flow cytometer systems, today announced the first recipient of its Accuri Flow Cytometer Creativity Awards program. Heather Newkirk, Ph.D., Executive Director of Business Development and Quality Assurance/Regulatory Affairs at Clinical Reference Laboratory, Inc. and an Assistant Professor of Medicine at the University of Missouri-Kansas City, will receive a free Accuri C6 Flow Cytometer(R) System. Accuri's twice-yearly Creativity Awards program was created to foster innovative research that taps the unrealized potential of flow cytometry and expands its use to novel applications that are newly possible as a result of the unique capabilities of the Accuri C6 system.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081211/NY51523 )

Explicitly designed for routine use by biomedical researchers in their own labs, Accuri's C6 Flow Cytometer is a full-featured bench-top cell analysis system that provides capabilities similar to industry leaders in a more user-friendly format and at a fraction of the cost of other flow cytometers.

"We are gratified by the quality and creativity of this first group of research proposals for our Creativity Awards program," said Grant Howes, an industry veteran who recently joined Accuri as Director of Marketing. "A key driver behind the development of the C6 system was our belief that the research power of flow cytometry has been hampered by its lack of wide accessibility. The diverse and imaginative responses to the first round of our Awards program provide concrete evidence that our accessible, affordable flow cytometer system can help unleash the full potential of flow cytometry."

Accuri designed the revolutionary C6 system from the ground up with input from hundreds of researchers who use flow cytometry, and it specially commissioned the easy-to-use cell analysis software that is a critical component of the approach. Accuri's innovations, coupled with its state-of-the-art components, result in a cytometer that is powerful, robust, compact and affordable, at less than one-third the cost of the current market leader.

Dr. Newkirk, the recipient of the first C6 Flow Cytometer System awarded by Accuri's Creativity Awards program, plans to use bead-based assays to detect direct genomic translocations, an approach that could be applied to a myriad of genomic rearrangements, including detecting specific translocations in certain cancers. She noted, "Flow cytometry offers researchers the chance to innovate in the design of a variety of assays, and I am excited by the opportunity to develop new assays to be performed on the C6 flow cytometer. It is encouraging to see that flow cytometry has been translated into a user-friendly, lower-cost system with the invention of the C6."

Dr. Newkirk will receive her C6 system early in 2009. It will be hers to keep, along with a year-long warranty as part of the award.

Jennifer Baird, CEO of Accuri, commented, "We are delighted to announce our first Accuri Flow Cytometer Creativity Awards winner. Dr. Newkirk's genomics research proposal is a fitting illustration of why we believe that the versatility and accessibility of our flow cytometer system will generate innovative research and a host of creative applications. We congratulate her and her team and look forward to seeing the fruits of their research, as well as many more proposals from researchers around the globe."

Learn more about the Accuri C6 Flow Cytometer System and the company's next upcoming Creativity Awards grant by visiting Booth 2023 at the 48th Annual Meeting of the American Society for Cell Biology in San Francisco from December 13-17, 2008, or at www.AccuriCytometers.com. Accuri Cytometers: Cell Analysis Within Reach(R).

About Accuri Cytometers

Accuri Cytometers, Inc. is an Ann Arbor-based life sciences company developing and marketing revolutionary high performance cell analysis systems designed to bring the power of flow cytometry into the labs of life sciences researchers everywhere. Reflecting the input of hundreds of researchers, the Accuri C6 Flow Cytometer(R) is a full-featured bench-top cell and bead analysis system that provides similar capabilities to those of industry-leading flow cytometers in an easy-to-use format and at a fraction of their cost. The Accuri system was engineered from the start to be compact, powerful and user-friendly, while also being affordable by most research laboratories. For more information, visit www.AccuriCytometers.com.

About Clinical Reference Laboratory

Established in 1979, Clinical Reference Laboratory, Inc. offers leading-edge testing services in the areas of Molecular Diagnostics, Clinical Trials, Toxicology, Insurance and Wellness testing. With a comprehensive test menu ranging from routine laboratory services to the latest in molecular testing, we are committed to providing high-quality science with a human touch. For more information, visit www.crlcorp.com

    For additional information, contact:
    Accuri Cytometers
    Jack Ball
    Chief Commercial Officer
    (734) 994-8000

    Media
    GendeLLindheim BioCom Partners
    Barbara Lindheim
    (212) 918-4650


'/>"/>
SOURCE Accuri Cytometers Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. UBC researchers discover gene mutation that causes eye cancer
2. Researchers report on convergence of technology
3. Einstein researchers discover protein that contributes to cancer spread
4. Researchers & Department of Defense Question Multiple Vaccine Administration
5. Researchers gain new insight on wonder of cell division
6. HALT-C researchers: Interferon as long-term treatment for hepatitis C not effective
7. Jefferson researcher awarded NIH grant
8. Researcher develops screening tool to identify patients with prediabetes
9. LA BioMed researchers among Southern California Super Doctors
10. Researchers discover new enzyme in cancer growth
11. Researchers identify cell group key to Lyme disease arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 28, 2017 , ... Accreditation Commission for Health Care (ACHC) ... America (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s ... Accreditation University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Getting enough sleep affects much more than ... (NSF), going just 19 hours without sleep can compromise motor reaction time, which can increase ... and Amica Insurance is sharing the following tips from the NSF to help you sleep ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back Surgery ... the revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified Anesthesiologist, ... patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike traditional ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... People are ... older people. “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa ... Hearing Associates of Greater Boston, in a NALA North American Speaker Series ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec Solutions ... Grove Foundation implement a Microsoft Dynamics GP solution that integrates to their PointClickCare ... that specializes in long-term care, Brooke Grove now has the capability to achieve ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... India , April 19, 2017 ... and Application, Forecast to 2022 report has covered and analysed ... statistics and information on market size, shares and growth factors. ... major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, ...
Breaking Medicine Technology: